Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-02

FDA Approved: BORTEZOMIB — Original Application (Hospira, Inc.)

View source ↗

Summary

FDA approved bortezomib under an original application, establishing its use in the treatment of multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bortezomib (bortezomib)

Snippet

ORIG AP for BORTEZOMIB (BORTEZOMIB)